Clinical epidemiological study of Hepatitis B and C release_2culpgevtbejxccv7zr5yjl2xe

by Abid Ali, Khalil-Ur-Rahman, Nazish Jahan, Mazhar Abbas

References

This release citing other releases
  1. Relation to clinical outcome in patients with chronic hepatitis B in Saudi Arabia 2006
  2. Epidemiologic study of chronic hepatitis B virus infection in male volunteer blood donors in Karachi 2005
  3. The past incidence of hepatitis C virus infection: implications for the future burden of chronic liver disease in the United States 2000
  4. Clinical and epidemiological features of patients with chronic hepatitis C co-infected with HIV 2006
  5. Peripheral neurotoxicity of pegylated interferon alpha 2006
  6. Pegylated Interferon Alfa-2b vs Standard Interferon Alfa-2b, Plus Ribavirin, for Chronic Hepatitis C in HIV-Infected Patients 2004
  7. Treatment of Hepatitis B e Antigen-Positive Chronic Hepatitis with Telbivudine or Adefovir 2007
  8. Pegylated Interferon Alfa-2b vs Standard Interferon Alfa2b, Plus Ribavirin, for Chronic Hepatitis C in HIVInfected Patients 2004
  9. Epidemiology of Hepatitis C Virus in Korea 2006
  10. Age-Related Response to Interferon Alfa Treatment in Women vs Men With Chronic Hepatitis C Virus Infection 1998
  11. Management of hepatitis B: summary of a clinical research workshop 2007
  12. Hepatitis B and C: prevalence and risk factors associated with seropositivity among children in Karachi 2006
  13. Hepatitis B genotypes correlate with clinical outcomes in patients with chronic hepatitis B 2000
  14. Hepatitis-B Surface Antigen (HBsAg) screening and vaccination experience in Tharparkar 2006
  15. Moleular, immunological and clinical properties of mutatede hepatitis B virus 2002
  16. Hapetitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures 2004
  17. Lamivudine for Patients with Chronic Hepatitis B and Advanced Liver Disease 2004
  18. Chronic hepatitis B 2007
  19. The relationship between therapeutic injections and high prevalence of hepatitis C infections in Hafizabad 1997
  20. A Clinico-pathological study of viral hepatitis 1987
  21. Prevalence of hepatitis B surface antigen and HCV antibodies in hepatocellular carcinoma cases in Karachi 1997
  22. Disease of liver and biliary system 2006
  23. HCV RNA Kinetic Response to PEGInterferon and Ribavirin in HIV Co-Infected Patients 2002
  24. Conf Retrovir Oppor Infect, Wash State Conv. Trade Cent. Feb
  25. Epidemiological Study of Hepatitis B and C in 34,336 Patients Operated at Hiroshima Prefectural Hospital during the Period from 1993
  26. Viral heterogeneity of the hepatitis C virus 1999
  27. Adefovir Dipivoxil for the Treatment of Hepatitis B e AntigenNegative Chronic Hepatitis B 2003
  28. Recombinant human interferon alfa-2b treatment for acute non-A, non-B hepatitis 1993
  29. Comparative study of patients with chronic hepatitis C virus infection due to genotypes 1 and 3 referred for treatment in southeast Brazil 2008
  30. Interferon alfa in the treatment of chronic viral hepatitis B and C 1997
  31. Peginterferon alfa-2a in patients with chronic hepatitis C 2000